Marla Weingarten
Director
Marla brings to Pangaea over 30 years of commercial experience in the pharmaceutical industry. Throughout her career, Marla has proven her ability to lead and motivate teams and to foster productive customer relationships both internally and externally and has skillfully managed different aspects of strategic development (e.g., business/brand planning, cross-functional leadership, market assessments). Marla identifies trends within the biopharmaceutical environment (regulatory, reimbursement, US legislation, prescribing influences, technology) and connects the dots to bring meaningful strategic interpretation of the changes shaping this industry as the leading author for Pangaea’s publication, Topics and Trends™.
Areas of expertise
- Business Strategy
- Corporate Strategy
Recent articles by Marla Weingarten
Pangaea Express: Section 232 tariffs announced on pharmaceuticals
April 7, 2026
Pangaea Express: Health Canada Extends Consultation Period for Clinical Trial Regulations
March 13, 2026
Pangaea Express: Nova Scotia Expands Prescribing for Pharmacists
February 25, 2026
Pangaea Express: Ontario Bans PPNs
November 10, 2025
Pangaea Express: Ontario Becoming FAST to Access
October 10, 2025
